The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Targeting IL-10 Family Cytokines for the Treatment of Human Diseases
Open accessAbstract
Members of the interleukin (IL)-10 family of cytokines play important roles in regulating immune responses during host defense but also in autoimmune disorders, inflammatory diseases, and cancer. Although IL-10 itself primarily acts on leukocytes and has potent immunosuppressive functions, other family members preferentially target nonimmune compartments, such as tissue epithelial cells, where they elicit innate defense mechanisms to control viral, bacterial, and fungal infections, protect tissue integrity, and promote tissue repair and regeneration. As cytokines are prime drug targets, IL-10 family cytokines provide great opportunities for the treatment of autoimmune diseases, tissue damage, and cancer. Yet no therapy in this space has been approved to date. Here, we summarize the diverse biology of the IL-10 family as it relates to human disease and review past and current strategies and challenges to target IL-10 family cytokines for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–253 of 253
Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development
Šturlan, S., Oberhuber, G., Beinhauer, B. G., Tichy, B., Kappel, S., Wang, J., & Rogy, M. A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.665 · Cited by 99
IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice
Kolumam, G. A., Wu, X., Lee, W. P., Hackney, J. A., Zavala‐Solorio, J., Gandham, V. D., Danilenko, D. M., Arora, P. S., Wang, X., & Ouyang, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170639 · Cited by 99
Self-citationRole of IL-22 in Microbial Host Defense
Eidenschenk, C., Rutz, S., Liesenfeld, O., & Ouyang, W. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-43492-5_10 · Cited by 93
Self-citationda Rocha, L. F., Duarte, Â. L. B. P., Dantas, A. T., Mariz, H. D. A., Pitta, I. D. R., Galdino, S. L., & Pitta, M. G. D. R. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111027 · Cited by 93
The role of interleukin-22 in hepatitis C virus infection
Dambacher, J., Beigel, F., Zitzmann, K., Heeg, M. H. J., Göke, B., Diepolder, H. M., Auernhammer, C. J., & Brand, S. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.016 · Cited by 89
Serum cytokine profile in patients with active lupus nephritis
Koenig, K., Gröschl, I., Pešičková, S. S., Tesař, V., Eisenberger, U., & Trendelenburg, M. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.004 · Cited by 89
Martín, R., Chain, F., Miquel, S., Natividad, J., Sokol, H., Verdú, E., Langella, P., & Bermúdez-Humarán, L. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28549 · Cited by 88
A xylose-inducible expression system forLactococcus lactis
Miyoshi, A., Jamet, E., Commissaire, J., Renault, P., Langella, P., & Azevedo, V. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.08.018 · Cited by 88
He, M., & Liang, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901829 · Cited by 88
Li, Q., Kawamura, K., Ma, G., Iwata, F., Numasaki, M., Suzuki, N., Shimada, H., & Tagawa, M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.002 · Cited by 86
Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation
Sakurai, N., Kuroiwa, T., Ikeuchi, H., Hiramatsu, N., Maeshima, A., Kaneko, Y., Hiromura, K., & Nojima, Y. (2008) · Rheumatology · doi:10.1093/rheumatology/ken061 · Cited by 86
Fox, B. A., Sheppard, P. O., & O’Hara, P. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004933 · Cited by 85
Marijnissen, R. J., Koenders, M. I., Smeets, R. L., Stappers, M. H. T., Nickerson‐Nutter, C. L., Joosten, L. A. B., Boots, A. M. H., & van den Berg, W. B. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30469 · Cited by 78
Regulation of interleukin-10 and interleukin-22 expression in T helper cells
Rutz, S., & Ouyang, W. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.018 · Cited by 77
Self-citationNagelkerken, L. M. (1997) · International Immunology · doi:10.1093/intimm/9.9.1243 · Cited by 73
Recombinant human interleukin 10 for induction of remission in Crohn's disease
Buruiana, F. E., Solà, I., & Alonso‐Coello, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005109.pub3 · Cited by 73
Adris, S., Klein, S., Jasnis, M. A., Chuluyán, E., Ledda, M. F., Bravo, A., Carbone, C., Chernajovsky, Y., & Podhajcer, O. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301012 · Cited by 72
Kobold, S., Völk, S., Clauditz, T. S., Küpper, N. J., Minner, S. J. P., Tufman, A., Duewell, P., Lindner, M., Koch, I., Heidegger, S. M., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829923c8 · Cited by 69
Biological Treatments in Atopic Dermatitis
Montes‐Torres, A., Llamas‐Velasco, M., Pérez-Plaza, A., Solano-López, G., & Sánchez-Pérez, J. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4040593 · Cited by 68
Stenderup, K., Rosada, C., Worsaae, A., Dagnæs‐Hansen, F., Steiniche, T., Hasselager, E., Iversen, L., Zahn, S., Wöldike, H. F., Holmberg, H. L., et al. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08890.x · Cited by 68
New Drugs and Treatment Targets in Psoriasis
Kofoed, K. F., Skov, L., & Zachariae, C. O. C. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-1931 · Cited by 65
Schwager, K., Bootz, F., Imesch, P., Kaspar, M., Trachsel, E., & Neri, D. (2011) · Human Reproduction · doi:10.1093/humrep/der195 · Cited by 61
Interleukin-19 blockade attenuates collagen-induced arthritis in rats
Hsu, Y.-H., Hsieh, P.-P., & Chang, M.-S. (2011) · Rheumatology · doi:10.1093/rheumatology/ker127 · Cited by 59
Sosman, J. A., Verma, A. K., Moss, S., Sorokin, P., Blend, M. J., Bradlow, B. A., Chachlani, N., Cutler, D. L., Sabo, R., Nelson, M. F., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02314.x · Cited by 55
Justa, S., Zhou, X., & Sarkar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093279 · Cited by 55
Yu, L., Wang, H.-Y., Yang, S.-P., Yuan, Z.-P., Xu, F., Sun, C., & Shi, R.-H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i17.2638 · Cited by 55
The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes
Hill, T., Krougly, O., Nikoopour, E., Bellemore, S. M., Lee‐Chan, E., Fouser, L. A., Hill, D. J., & Singh, B. (2013) · Cell Regeneration · doi:10.1186/2045-9769-2-2 · Cited by 55
Interferon-Lambda as a Potential Therapeutic Agent in Cancer Treatment
Steen, H. C., & Gamero, A. M. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0058 · Cited by 53
Sun, D., Yeh, C., So, E. C., Wang, L.-Y., Wei, T.-S., Chang, M., & Hsing, C. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.017 · Cited by 51
Interleukin-29 Binds to Melanoma Cells Inducing Jak-STAT Signal Transduction and Apoptosis
Guenterberg, K. D., Grignol, V. P., Raig, E. T., Zimmerer, J. M., Chan, A. N., Blaskovits, F. M., Young, G. S., Nuovo, G. J., Mundy-Bosse, B. L., Lesinski, G. B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0461 · Cited by 51
Interleukin-22 Protects against Acute Alcohol-Induced Hepatotoxicity in Mice
Xing, W., Zou, M., Liu, S., et al. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110061 · Cited by 48
Interleukin 24: Mechanisms and therapeutic potential of an anti-cancer gene
Whitaker, E. L., Filippov, V. A., & Duerksen-Hughes, P. J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.08.004 · Cited by 47
Zurita-Turk, M., del Carmen, S., Santos, A. C., Pereira, V. B., Cara, D. C., Leclercq, S. Y., de LeBlanc, A. D. M., Azevedo, V., Chatel, J., LeBlanc, J. G., et al. (2014) · BMC Biotechnology · doi:10.1186/1472-6750-14-73 · Cited by 47
del Carmen, S., de LeBlanc, A. D. M., Perdigón, G., Pereira, V. B., Miyoshi, A., Azevedo, V., & LeBlanc, J. G. (2011) · Microbial Physiology · doi:10.1159/000333830 · Cited by 46
Integrative Biology Approach Identifies Cytokine Targeting Strategies for Psoriasis
Perera, G. K., Ainali, C., Semenova, E., Hundhausen, C., Barinaga, G., Kassen, D., Williams, A. E., Mirza, M. M., Balázs, M., Wang, X., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007217 · Cited by 46
Self-citationLi, W., Danilenko, D. M., Bunting, S., Ganesan, R., Sa, S., Ferrando, R. E., Wu, T. D., Kolumam, G. A., Ouyang, W., & Kirchhofer, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806267200 · Cited by 45
Self-citationdel Carmen, S., Martín, R., Saraiva, T. D. L., Zurita-Turk, M., Miyoshi, A., Azevedo, V., de LeBlanc, A. D. M., Langella, P., Bermúdez‐Humarán, L. G., & LeBlanc, J. G. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000235 · Cited by 45
Wang, Z., Yang, L., Jiang, Y., Ling, Z., Li, Z., Cheng, Y., Huang, H., Wang, L., Pan, Y., Wang, Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023737 · Cited by 44
In Search of Magic Bullets: The Golden Age of Immunotherapeutics
O’Shea, J. J., Kanno, Y., & Chan, A. C. (2014) · Cell · doi:10.1016/j.cell.2014.03.010 · Cited by 44
Šenolt, L., Leszczyński, P., Dokoupilová, E., Göthberg, M., Valencia, X., Hansen, B. B., & Cañete, J. D. D. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39083 · Cited by 42
Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth
Lasfar, A., de la Torre, A., Abushahba, W., Cohen-Solal, K., Castaneda, I., Yuan, Y., Reuhl, K. R., Zloza, A., Raveche, E. S., Laskin, D. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10272 · Cited by 42
Cannella, F., Scagnolari, C., Selvaggi, C., Stentella, P., Recine, N., Antonelli, G., & Pierangeli, A. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0330-9 · Cited by 39
Mechanisms of interleukin-22’s beneficial effects in acute pancreatitis
Huan, C., Kim, D., Ou, P., Alfonso, A., & Stanek, A. (2016) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v7.i1.108 · Cited by 38
Preclinical Safety Evaluation of Recombinant Human Interleukin-10
Rosenblum, I., Johnson, R. C., & Schmahai, T. J. (2002) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2001.1504 · Cited by 36
Innate Lymphoid Cells in Graft-Versus-Host Disease
Kónya, V., & Mjösberg, J. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13394 · Cited by 35
IL‐24: a classic cytokine and/or a potential cure for cancer?
Kreis, S., Philippidou, D., Margue, C., & Behrmann, I. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00372.x · Cited by 34
Recombinant Interleukin-24 Lacks Apoptosis-Inducing Properties in Melanoma Cells
Kreis, S., Philippidou, D., Margue, C., Rolvering, C., Haan, C., Dumoutier, L., Renauld, J., & Behrmann, I. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001300 · Cited by 34
Bosanquet, D. C., Harding, K. G., Ruge, F., Sanders, A. J., & Jiang, W. G. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00840.x · Cited by 29
Ultraviolet B Light Stimulates lnterleukin‐20 Expression by Human Epithelial Keratinocytes
Hunt, D. W. C., Boivin, W. A., Fairley, L. A., Jovanovic, M. M., King, D. E., Salmon, R. A., & Utting, O. (2006) · Photochemistry and Photobiology · doi:10.1562/2005-08-31-ra-668 · Cited by 25
Gottlieb, A. B., Krueger, J. G., Lundblad, M. S., Göthberg, M., & Skolnick, B. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134703 · Cited by 23
Induction of inflammatory bowel disease accelerates adenoma formation in Min +/− mice
Huang, E. H., PARK, J., Appelman, H. D., Weinberg, A. M., BANERJEE, M., LOGSDON, C., & SCHMIDT, A. (2006) · Surgery · doi:10.1016/j.surg.2005.11.005 · Cited by 23
Dejaco, C., Reinisch, W., Lichtenberger, C., Waldhoer, T., Kuhn, I., Tilg, H., & Gasché, C. (2000) · Journal of Investigative Medicine · doi:10.1177/108155890004800616 · Cited by 10
Recombinant human interleukin 10 for induction of remission in Crohn's disease
Jolicoeur, E., McDonald, J., & MacDonald, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005109 · Cited by 2
Cited by
Biology and therapeutic potential of interleukin-10
Saraiva, M., Vieira, P., & O’Garra, A. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190418 · Cited by 1,118
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,072
Self-citationHost–microbiota interactions in inflammatory bowel disease
Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 780
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Tie, Y., Tang, F., Wei, Y.-Q., & Wei, X.-W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01282-8 · Cited by 591
The role of IL-22 in intestinal health and disease
Keir, M. E., Yi, T., Lu, T. T., & Ghilardi, N. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192195 · Cited by 464
Metadata
- Authors
- Wang, X., Wong, K., Ouyang, W., & Rutz, S.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-10-16
- Volume
- 11
- Issue
- 2
- Pages
- a028548
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2765414700
- Cited by
- 302
- References
- 253
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.